百时美施贵宝Bristol Myers Squibb Co. (BMY) 2013年年度报告「NYSE」.pdf

1、2013 Annual Report5asdEVOLVING TO A SPECIALTY CARE BIOPHARMA COMPANYDina Sienkiewicz,pictured here with her husband,Vinny,participated in an investigational clinical trial of the combination use of experimental immune-based therapies from Bristol-Myers Squibb.The patient stories shared in this Annua

2、l Report depict individual patient responses to our medicines or investigational compounds and are not representative of all patient responses.In addition,there is no guarantee that potential drugs or indications still in development will receive regulatory approval.AS THE EXTERNAL ENVIRONMENT conti

3、nues to change posing both challenges and opportunities Bristol-Myers Squibb has successfully adapted and evolved.Throughout our history,this strategic resilience has allowed us to adhere to our Mission.Moreover,it has enabled us to keep pace with an ability to address the critical needs of todays p

4、atients,while building a company that can create extraordinary possibilities for making a difference in the lives of people in the years ahead.ON THE COVERAfter Dina Sienkiewicz,46,of Woodbury,Connecticut(pictured here with her husband,Vinny),was diagnosed with stage 4 mucosal melanoma,a relatively

5、rare type of cancer that invades mucosal surfaces of the body,she began to shorten her goals.“I just wanted to live long enough to see my daughter graduate high school and know that she was going off to college.”Now,three years later,her daughter is a college junior studying to be a physicians assis

6、tant,and Sienkiewicz is on the Internet every night,trying to help her“cancer buddies,”who share her form of cancer.Her cancer had spread,even after two surgeries,and her surgeon admitted there was“no clear blueprint”for what to do next.Thats when Sienkiewicz went to see Dr.Mario Sznol,the clinical